• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性危重病/持续性炎症免疫抑制和分解代谢患者的临床及预后特征:一项前瞻性观察性临床研究

CLINICAL AND PROGNOSTIC FEATURES OF CHRONIC CRITICAL ILLNESS/PERSISTENT INFLAMMATION IMMUNOSUPPRESSION AND CATABOLISM PATIENTS: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY.

作者信息

Zhou Qingqing, Qian Hebu, Yang Aixiang, Lu Jian, Liu Jun

机构信息

Gusu School of Nanjing Medical University, Department of Critical Care Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou Clinical Medical Center of Critical Care Medicine, Suzhou 215001, China.

Department of Critical Care Medicine, Suzhou Ninth People's Hospital, The Affiliated Wujiang Hospital of Nantong University, Suzhou 215200, China.

出版信息

Shock. 2023 Jan 1;59(1):5-11. doi: 10.1097/SHK.0000000000002035. Epub 2022 Nov 17.

DOI:10.1097/SHK.0000000000002035
PMID:36383370
Abstract

Objective: The aims of this study were to investigate and compare the clinical features and prognosis of chronic critical illness (CCI)/persistent inflammation immunosuppression and catabolism (PICS). Methods: This is a prospective observational clinical study. During this study period, we collect intensive care unit patients' data from Suzhou Municipal Hospital and Suzhou Ninth People's Hospital. All patients older than 18 years were included, and according to the corresponding exclusion and diagnostic criteria, they were divided into four groups: PICS group, CCI group, CCI and PICS group (CCI + PICS), and neither CCI nor PICS group (NCCI + NPICS) and collected and recorded age, sex, hospital time, hospital diagnosis, Acute Physiology and Chronic Health Evaluation II score, Sequential Organ Failure Assessment score, C-reactive protein, absolute value lymphocyte count, serum albumin, white blood cell count, absolute value neutrophil count, secondary infection, and 28-day case fatality rate separately. Results: A total of 687 patients were admitted to the intensive care unit during the study period. The hospitalization time less than 14 days were excluded, and 168 patients were eventually included. There are 17 in the PICS group, 71 in the CCI group, 50 in the CCI + PICS group, and 30 in the NCCI + NPICS group. Baseline characteristics showed statistically significant differences in Sequential Organ Failure Assessment, length of hospital stay, and 28-day mortality among four groups. Baseline main indicator and multiple comparisons showed that the CCI + PICS group had longer hospital stay, worse prognosis, and more adverse outcomes. Multivariate analysis showed that final age, C-reactive protein on days 14 and 21, and serum albumin on days 1 and 21 had an impact on the prognosis ( P < 0.05). Conclusion: The clinical prognosis of the four groups decreased in order of NCCI + NPICS, CCI, PICS, and CCI + PICS. Our finding of clinically isolated PICS may indicate that PICS acts as an inducement or independent factor to worsen the prognosis of CCI.

摘要

目的

本研究旨在调查和比较慢性危重病(CCI)/持续性炎症免疫抑制和分解代谢(PICS)的临床特征及预后。方法:这是一项前瞻性观察性临床研究。在研究期间,我们收集了苏州市立医院和苏州第九人民医院重症监护病房患者的数据。纳入所有年龄大于18岁的患者,并根据相应的排除和诊断标准,将他们分为四组:PICS组、CCI组、CCI合并PICS组(CCI + PICS)和既无CCI也无PICS组(NCCI + NPICS),分别收集并记录年龄、性别、住院时间、医院诊断、急性生理与慢性健康状况评分系统II评分、序贯器官衰竭评估评分、C反应蛋白、淋巴细胞绝对值计数、血清白蛋白、白细胞计数、中性粒细胞绝对值计数、继发感染及28天病死率。结果:研究期间共有687例患者入住重症监护病房。排除住院时间少于14天的患者,最终纳入168例患者。PICS组17例,CCI组71例,CCI + PICS组50例,NCCI + NPICS组30例。基线特征显示四组在序贯器官衰竭评估、住院时间和28天死亡率方面存在统计学显著差异。基线主要指标及多重比较显示,CCI + PICS组住院时间更长、预后更差且不良结局更多。多因素分析显示,最终年龄、第14天和第21天的C反应蛋白以及第1天和第21天的血清白蛋白对预后有影响(P < 0.05)。结论:四组的临床预后按NCCI + NPICS、CCI、PICS、CCI + PICS的顺序依次降低。我们关于临床孤立性PICS的发现可能表明,PICS是使CCI预后恶化的诱因或独立因素。

相似文献

1
CLINICAL AND PROGNOSTIC FEATURES OF CHRONIC CRITICAL ILLNESS/PERSISTENT INFLAMMATION IMMUNOSUPPRESSION AND CATABOLISM PATIENTS: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY.慢性危重病/持续性炎症免疫抑制和分解代谢患者的临床及预后特征:一项前瞻性观察性临床研究
Shock. 2023 Jan 1;59(1):5-11. doi: 10.1097/SHK.0000000000002035. Epub 2022 Nov 17.
2
Predictive value of mNUTRIC score for chronic critical illness in patients of sepsis complicated with ARDS.mNUTRIC评分对脓毒症合并急性呼吸窘迫综合征患者慢性危重病的预测价值
Technol Health Care. 2025 Mar;33(2):831-837. doi: 10.1177/09287329241296430. Epub 2024 Nov 15.
3
Risk factors, biomarkers, and mechanisms for persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a systematic review and meta-analysis.持续炎症、免疫抑制和分解代谢综合征(PICS)的风险因素、生物标志物和机制:系统评价和荟萃分析。
Br J Anaesth. 2024 Sep;133(3):538-549. doi: 10.1016/j.bja.2024.03.038. Epub 2024 Apr 30.
4
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2.常规实验室检测对预测 SARS-CoV-2 感染者死亡和病情恶化为重症或危重症 COVID-19 的准确性。
Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015050. doi: 10.1002/14651858.CD015050.pub2.
7
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
8
Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit.对重症监护病房中的成年重症患者进行早期干预(活动或主动锻炼)。
Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD010754. doi: 10.1002/14651858.CD010754.pub2.
9
[Predictive value of plasma exosome count for the prognosis in septic patients].[血浆外泌体计数对脓毒症患者预后的预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Jul;36(7):687-692. doi: 10.3760/cma.j.cn121430-20230717-00529.
10
Glutamine supplementation for critically ill adults.对危重症成年患者补充谷氨酰胺
Cochrane Database Syst Rev. 2014 Sep 9;2014(9):CD010050. doi: 10.1002/14651858.CD010050.pub2.

引用本文的文献

1
Intraoperative lactate level correlated with the length of hospital stay in patients with intraoperative hypothermia.术中低体温患者的术中乳酸水平与住院时间相关。
Medicine (Baltimore). 2025 Jul 4;104(27):e43168. doi: 10.1097/MD.0000000000043168.
2
Why should lymphocytes immune profile matter in sepsis?为什么淋巴细胞免疫谱在脓毒症中很重要?
World J Crit Care Med. 2025 Jun 9;14(2):98791. doi: 10.5492/wjccm.v14.i2.98791.
3
Development and validation of clinical criteria for critical illness-associated immune dysfunction: based on the MIMIC-IV database.
危重症相关免疫功能障碍临床标准的制定与验证:基于MIMIC-IV数据库
Front Med (Lausanne). 2024 Dec 11;11:1465397. doi: 10.3389/fmed.2024.1465397. eCollection 2024.
4
Definitions, epidemiology, and outcomes of persistent/chronic critical illness: a scoping review for translation to clinical practice.持续性/慢性危重病的定义、流行病学及转归:一项转化为临床实践的范围综述
Crit Care. 2024 Dec 28;28(1):435. doi: 10.1186/s13054-024-05215-4.
5
Risk factors, biomarkers, and mechanisms for persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a systematic review and meta-analysis.持续炎症、免疫抑制和分解代谢综合征(PICS)的风险因素、生物标志物和机制:系统评价和荟萃分析。
Br J Anaesth. 2024 Sep;133(3):538-549. doi: 10.1016/j.bja.2024.03.038. Epub 2024 Apr 30.
6
Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities.持续炎症、免疫抑制和分解代谢综合征(PICS):定义、潜在治疗方法和研究重点的综述。
Br J Anaesth. 2024 Mar;132(3):507-518. doi: 10.1016/j.bja.2023.11.052. Epub 2024 Jan 4.